Attention Pharmacists and Pharmacy Techs: NEW CE REQUIREMENTS! More Information
This home-study activity describes the impact of hyperglycemia in the critical care setting, as well as research on the development of clinical targets for optimal glycemic control.
Choose from the criteria below to find an activity that fits you best.
Three million Americans have celiac disease, and the only treatment for this life-long ailment is the implementation of a gluten-free diet. As gluten is found in medication, pharmacy care is critical in the treatment of this disorder. Celiac disease is a genetic, autoimmune disease that damages the small intestines and interferes with the absorption of nutrients from food. When people with celiac ingest gluten, the protein in wheat, barley and rye, the whole body is affected causing a myriad of symptoms. This common disease affects one percent of the U.S. population! Another six percent of the population is gluten-intolerant, greatly increasing the number of people needing to follow the gluten-free diet. This continuing education activity will provide pharmacists with a reliable understanding of celiac disease and their role in dealing with gluten-intolerant patients.
Upon completion of this activity, pharmacists will be able to:
Robert A. Mangione, Ed.D, R.Ph.
Dean and Professor
St. John's University, College of Pharmacy and Allied Health Professions
Loretta Jay, MA
Director of Program Development
National Foundation for Celiac Awareness
James H. Wisner, BBA, MBA
President, Wisner Marketing Group, Inc.
It is the policy of ProCE to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation. Mr. Wisner has disclosed that he has served as a consultant and/or speaker for the Perrigo Company. Dr. Mangione and Ms. Jay report having no relationships to disclose.
Please note: The opinions expressed in this activity should not be construed as those of the CE provider or Cardinal Health. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs for unlabeled indications. Use of drugs outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.
Release Date: 03-07-2011
Expiration Date: 03-07-2014
This activity is co-sponsored by ProCE, Inc. and the National Foundation for Celiac Awareness. ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 221-999-11-021-H01-P has been assigned to this knowledge-based home-study CE activity (initial release date 03-07-11). This activity is approved for 1.5 contact hours (0.15 CEUs) in states that recognize ACPE providers. The activity is provided at no cost to participants. Statements of credit will be issued online upon completion of the activity evaluation and the post-test with a score of 70% or higher. No partial credit will be given.
This activity was supported by an unrestricted educational grant from Perrigo.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.